<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Covalon Technologies Ltd. — News on 6ix</title>
<link>https://6ix.com/company/covalon-technologies-ltd</link>
<description>Latest news and press releases for Covalon Technologies Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 15 Apr 2026 21:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/covalon-technologies-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f2aa78dffbe2df12e02f.webp</url>
<title>Covalon Technologies Ltd.</title>
<link>https://6ix.com/company/covalon-technologies-ltd</link>
</image>
<item>
<title>Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-technologies-reports-significant-milestones-spanning-vascular-access-infection-prevention-and-wound-care</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-technologies-reports-significant-milestones-spanning-vascular-access-infection-prevention-and-wound-care</guid>
<pubDate>Wed, 15 Apr 2026 21:30:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (TSX: COV; OTCQX: CVALF), an advanced medical technologies company, tod...</description>
</item>
<item>
<title>Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-to-showcase-clinical-innovation-and-infection-prevention-leadership-at-infusion-nurses-society-2026-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-to-showcase-clinical-innovation-and-infection-prevention-leadership-at-infusion-nurses-society-2026-annual-meeting</guid>
<pubDate>Fri, 10 Apr 2026 19:23:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, to...</description>
</item>
<item>
<title>Covalon Announces Grant of Deferred Share Units</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-grant-of-deferred-share-units</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-grant-of-deferred-share-units</guid>
<pubDate>Fri, 27 Mar 2026 21:03:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-voting-results-from-fiscal-2025-annual-general-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-voting-results-from-fiscal-2025-annual-general-and-special-meeting-of-shareholders</guid>
<pubDate>Thu, 26 Mar 2026 11:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-to-hold-annual-meeting-of-shareholders-on-wednesday-march-25-2026</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-to-hold-annual-meeting-of-shareholders-on-wednesday-march-25-2026</guid>
<pubDate>Wed, 18 Mar 2026 11:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-reports-on-2026-first-quarter-results-and-recent-achievements-and-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-reports-on-2026-first-quarter-results-and-recent-achievements-and-highlights</guid>
<pubDate>Wed, 25 Feb 2026 12:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-honoured-to-partner-with-the-association-for-vascular-access-and-global-expert-dr-nancy-moureau-to-tackle-critical-iv-therapy-complications</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-honoured-to-partner-with-the-association-for-vascular-access-and-global-expert-dr-nancy-moureau-to-tackle-critical-iv-therapy-complications</guid>
<pubDate>Thu, 19 Feb 2026 21:15:00 GMT</pubDate>
<description>MISSISSAUGA, Ontario, February 19, 2026--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety and clinical outcomes, today announced an upcoming Continuing Education webinar to be presented by internationally recognized vascular access expert Dr. Nancy Moureau and hosted by the distinguished Association for Vascular Access (AVA), a leading global authority on vascular access.</description>
</item>
<item>
<title>Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-conference-call-to-discuss-first-quarter-fiscal-2026-results</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-conference-call-to-discuss-first-quarter-fiscal-2026-results</guid>
<pubDate>Thu, 19 Feb 2026 12:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-reports-highest-revenue-quarter-of-fiscal-year-2025-delivers-third-consecutive-year-of-revenue-growth</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-reports-highest-revenue-quarter-of-fiscal-year-2025-delivers-third-consecutive-year-of-revenue-growth</guid>
<pubDate>Thu, 11 Dec 2025 12:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-conference-call-to-discuss-fourth-quarter-and-year-end-fiscal-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-conference-call-to-discuss-fourth-quarter-and-year-end-fiscal-2025-financial-results</guid>
<pubDate>Thu, 04 Dec 2025 12:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-technologies-ltd-announces-payment-of-first-ever-dividend-marking-a-milestone-in-financial-strength</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-technologies-ltd-announces-payment-of-first-ever-dividend-marking-a-milestone-in-financial-strength</guid>
<pubDate>Wed, 19 Nov 2025 22:30:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the &#x201C;Company&#x201D; or &#x201C;Covalon&#x201D;) (TSXV: COV; OT...</description>
</item>
<item>
<title>Covalon Declares First Ever Special Cash Dividend</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-declares-first-ever-special-cash-dividend</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-declares-first-ever-special-cash-dividend</guid>
<pubDate>Tue, 21 Oct 2025 11:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the &#x201C; Company&#x201D; or &#x201C; Covalon&#x201D; ) (TS...</description>
</item>
<item>
<title>Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-to-participate-in-the-planet-microcap-showcase-toronto-on-october-22-2025</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-to-participate-in-the-planet-microcap-showcase-toronto-on-october-22-2025</guid>
<pubDate>Mon, 20 Oct 2025 11:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/empowering-nurses-with-innovation-covalon-showcases-patient-safety-solutions-to-tackle-preventable-complications-at-ancc-national-magnet-and-pathway-conference</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/empowering-nurses-with-innovation-covalon-showcases-patient-safety-solutions-to-tackle-preventable-complications-at-ancc-national-magnet-and-pathway-conference</guid>
<pubDate>Tue, 07 Oct 2025 11:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced m...</description>
</item>
<item>
<title>Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-presents-evidence-backed-innovations-making-a-difference-for-critically-ill-children-at-aphon</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-presents-evidence-backed-innovations-making-a-difference-for-critically-ill-children-at-aphon</guid>
<pubDate>Thu, 25 Sep 2025 11:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-departure-of-executive-chair-and-the-appointment-of-its-largest-shareholder-as-new-chair</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-departure-of-executive-chair-and-the-appointment-of-its-largest-shareholder-as-new-chair</guid>
<pubDate>Tue, 23 Sep 2025 21:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/evidence-driven-outcomes-and-clinical-innovation-highlight-covalons-presence-at-the-association-for-vascular-access-2025-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/evidence-driven-outcomes-and-clinical-innovation-highlight-covalons-presence-at-the-association-for-vascular-access-2025-annual-meeting</guid>
<pubDate>Thu, 18 Sep 2025 11:00:00 GMT</pubDate>
<description>Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...</description>
</item>
<item>
<title>Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/evidence-driven-outcomes-clinical-innovation-110000944</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/evidence-driven-outcomes-clinical-innovation-110000944</guid>
<pubDate>Thu, 18 Sep 2025 11:00:00 GMT</pubDate>
<description>MISSISSAUGA, Ontario, September 18, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation at the Association for Vascular Access (AVA) Annual Scientific Meeting in Orlando, Florida, from September 18–21, 2025. Attendees will have the opportunity to explore Covalon’s innovative vascular access and infection prevention solutions and learn why leading hospitals in the United States and beyond are</description>
</item>
<item>
<title>Covalon Announces Publication of Impactful VALGuard&#xAE; Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-publication-of-impactful-valguardandxae-line-guard-clinical-study-demonstrating-significant-reduction-in-central-line-associated-blood-stream-infections-clabsis</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-publication-of-impactful-valguardandxae-line-guard-clinical-study-demonstrating-significant-reduction-in-central-line-associated-blood-stream-infections-clabsis</guid>
<pubDate>Tue, 16 Sep 2025 11:00:00 GMT</pubDate>
<description>Peer-reviewed study reports a 78% reduction in hospital-wide CLABSI rates from 2023 to 2024 ...</description>
</item>
<item>
<title>Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)</title>
<link>https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-publication-impactful-valguard-110000315</link>
<guid isPermaLink="true">https://6ix.com/company/covalon-technologies-ltd/news/covalon-announces-publication-impactful-valguard-110000315</guid>
<pubDate>Tue, 16 Sep 2025 11:00:00 GMT</pubDate>
<description>MISSISSAUGA, Ontario, September 16, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of results from a peer-reviewed clinical study investigating the use of Covalon’s VALGuard® Vascular Access Line Guard in the Journal of the Association for Vascular Access (JAVA). Conducted at the Children’s Hospital at Montefiore, a nationally ranked U.S. pediatric hospital, the study, titled "Evalu</description>
</item>
</channel>
</rss>